2
A randomized study of alglucosidase alfa in late-onset Pompe's disease.   
N Engl J Med 2010 Apr 15;362(15):1396-1406   abstract
_______________________________________________________________

3
Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma.   
Chest 2010 Apr;137(4):790-796   abstract
_______________________________________________________________

4
Vitamin D levels, lung function, and steroid response in adult asthma.   
Am J Respir Crit Care Med 2010 Apr 1;181(7):699-704   abstract
_______________________________________________________________

5
Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.   
Am J Respir Crit Care Med 2010 Apr 1;181(7):676-687   abstract
_______________________________________________________________

6
A critical role for the g protein-coupled receptor mFPR2 in airway inflammation and immune responses.   
J Immunol 2010 Apr 1;184(7):3331-3335   abstract
_______________________________________________________________

7
IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis.   
J Immunol 2010 Apr 1;184(7):3768-3779   abstract
_______________________________________________________________

8
TLR4 signaling in stromal cells is critical for the initiation of allergic Th2 responses to inhaled antigen.   
J Immunol 2010 Apr 1;184(7):3535-3544   abstract
_______________________________________________________________

9
The FDA and safe use of long-acting beta-agonists in the treatment of asthma.   
N Engl J Med 2010 Apr 1;362(13):1169-1171   abstract
_______________________________________________________________

10
C1 inhibitor therapy and hereditary angioedema.   
Am J Med 2010 Apr;123(4):e15   abstract
_______________________________________________________________

11
Upper respiratory infections.   
Am J Med 2010 Apr;123(4 Suppl):S16-S25   abstract
_______________________________________________________________

12
Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events.   
Am J Med 2010 Apr;123(4):322-328   abstract
_______________________________________________________________

13
Confusion about epinephrine dosing leading to iatrogenic overdose: a life-threatening problem with a potential solution.   
Ann Emerg Med 2010 Apr;55(4):341-344   abstract
_______________________________________________________________

14
Mepolizumab in refractory eosinophilic asthma.   
Thorax 2010 Apr;65(4):370   abstract
_______________________________________________________________

15
Is postmenopausal HRT a risk factor for adult-onset asthma?   
Thorax 2010 Apr;65(4):282-284   abstract
_______________________________________________________________

16
Postmenopausal hormone therapy and asthma onset in the E3N cohort.   
Thorax 2010 Apr;65(4):292-297   abstract
_______________________________________________________________

17
In-vitro-induced Th17 cells fail to induce inflammation in vivo and show an impaired migration into inflamed sites.   
Eur J Immunol 2010 Apr;40(4):1089-1098   abstract
_______________________________________________________________

18
Exercise-induced vasculitis.   
Arch Dermatol 2010 Apr;146(4):449-1   abstract
_______________________________________________________________

19
Golfer's vasculitis vs cutaneous vasculitis exacerbated by activity.   
Arch Dermatol 2010 Apr;146(4):449-450   abstract
_______________________________________________________________

20
Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial.   
Arch Dermatol 2010 Apr;146(4):446-449   abstract
_______________________________________________________________

21
Novel asthma-associated genes from genome-wide association studies: what is their significance?   
Chest 2010 Apr;137(4):909-915   abstract
_______________________________________________________________

22
Meeting the obligation to balance bioethics and clinical trial design in asthma.   
Am J Respir Crit Care Med 2010 Apr 1;181(7):648-650   abstract
_______________________________________________________________

23
Genetics, ethics, and the use of long-acting beta-adrenergics to treat asthma.   
Am J Respir Crit Care Med 2010 Apr 1;181(7):647-648   abstract
_______________________________________________________________

24
FDA offers advice to reduce risks of long-acting beta-agonists in asthma care.   
JAMA 2010 Apr 14;303(14):1353-1354   abstract
_______________________________________________________________

25
MMP12, lung function, and COPD in high-risk populations.   
N Engl J Med 2010 Apr 1;362(13):1241   abstract
_______________________________________________________________

26
Everolimus-eluting versus paclitaxel-eluting stents.   
Lancet 2010 Apr 3;375(9721):1161-1162   abstract
_______________________________________________________________

27
Short-term effects of PM10 and NO2 on respiratory health among children with asthma or asthma-like symptoms: a systematic review and meta-analysis.   
Environ Health Perspect 2010 Apr;118(4):449-457   abstract
_______________________________________________________________

28
Effects of diisononyl phthalate on atopic dermatitis in vivo and immunologic responses in vitro.   
Environ Health Perspect 2010 Apr;118(4):472-478   abstract
_______________________________________________________________

29
Severe type 1-allergy to raw bell pepper. [German]   
Hautarzt 2010 Apr;61(4):339-342   abstract
_______________________________________________________________

30
Delayed hypersensitivity to methylchloroisothiazolinone/methylisothiazolinone not detected by the baseline series of the Spanish group.   
Contact Dermatitis 2010 Apr;62(4):250-251   abstract
_______________________________________________________________

31
Allergic contact dermatitis due to cosmetics containing vitamin K1 oxide.   
Contact Dermatitis 2010 Apr;62(4):248-250   abstract
_______________________________________________________________

32
Twenty-five years quaternium-15 in the European baseline series: does it deserve its place there?   
Contact Dermatitis 2010 Apr;62(4):210-220   abstract
_______________________________________________________________

33
Contact allergy to gold as a model for clinical-experimental research.   
Contact Dermatitis 2010 Apr;62(4):193-200   abstract
_______________________________________________________________

34
Combined vasomodulatory therapy for severe pulmonary hypertension in chronic hypersensitivity pneumonitis.   
Med Sci Monit 2010 Apr 28;16(5):CS55-CS57   abstract
_______________________________________________________________

35
Gene polymorphism of epidermal growth factor receptor and airway hyperresponsiveness in young allergic subjects without respiratory symptoms.   
Med Sci Monit 2010 Apr 1;16(4):CR163-CR171   abstract
_______________________________________________________________

36
Formaldehyde-releasers in cosmetics in the USA and in Europe.   
Contact Dermatitis 2010 Apr;62(4):221-224   abstract
_______________________________________________________________

37
Assessment of nickel release from earrings randomly purchased in China and Thailand using the dimethylglyoxime test.   
Contact Dermatitis 2010 Apr;62(4):232-240   abstract
_______________________________________________________________

38
Dermatitis from common ivy (Hedera helix L. subsp. helix) in Europe: past, present, and future.   
Contact Dermatitis 2010 Apr;62(4):201-209   abstract
_______________________________________________________________

39
Drug rash with eosinophilia and systemic symptoms secondary to sulfasalazine.   
J Paediatr Child Health 2010 Apr;46(4):193-196   abstract
_______________________________________________________________

40
Vocal cord dysfunction: beyond severe asthma.   
Respir Med 2010 Apr;104(4):504-509   abstract
_______________________________________________________________

41
Rhinitis in subjects with work-exacerbated asthma.   
Respir Med 2010 Apr;104(4):497-503   abstract
_______________________________________________________________

42
Low-dose fluticasone propionate with and without salmeterol in steroid-naive patients with mild, uncontrolled asthma.   
Respir Med 2010 Apr;104(4):510-517   abstract
_______________________________________________________________

43
Inhibition of Pyk2 blocks airway inflammation and hyperresponsiveness in a mouse model of asthma.   
Am J Respir Cell Mol Biol 2010 Apr;42(4):491-497   abstract
_______________________________________________________________

44
Airway wall expression of OX40/OX40L and interleukin-4 in asthma.   
Chest 2010 Apr;137(4):797-804   abstract
_______________________________________________________________

45
Levels of soluble human leukocyte antigen-G are increased in asthmatic airways.   
Eur Respir J 2010 Apr;35(4):925-927   abstract
_______________________________________________________________

46
YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E.   
Eur Respir J 2010 Apr;35(4):757-760   abstract
_______________________________________________________________

47
Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis?   
Eur Respir J 2010 Apr;35(4):730-734   abstract
_______________________________________________________________

48
Lung function and bronchodilator response in 4-year-old children with different wheezing phenotypes.   
Eur Respir J 2010 Apr;35(4):865-872   abstract
_______________________________________________________________

49
Outpatient urticaria diagnosis codes have limited predictive value for same-day influenza vaccine adverse event detection.   
J Clin Epidemiol 2010 Apr;63(4):407-411   abstract
_______________________________________________________________

50
Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma.   
Eur Respir J 2010 Apr;35(4):750-756   abstract
_______________________________________________________________

51
Interleukin-17A activation on bronchial epithelium and basophils: a novel inflammatory mechanism.   
Eur Respir J 2010 Apr;35(4):883-893   abstract
_______________________________________________________________

52
Occupational asthma caused by the predatory beneficial mites Amblyseius californicus and Amblyseius cucumeris.   
Occup Environ Med 2010 Apr;67(4):287   abstract
_______________________________________________________________

53
How will their airways be? Respiratory health 15 years after the start of apprenticeship.   
Occup Environ Med 2010 Apr;67(4):219-220   abstract
_______________________________________________________________

54
Bullous Sweet's syndrome and pseudolymphoma precipitated by IL-2 therapy.   
Cutis 2010 Apr;85(4):206-213   abstract
_______________________________________________________________

55
Botanical briefs: poisonwood (Metopium toxiferum).   
Cutis 2010 Apr;85(4):178-179   abstract
_______________________________________________________________

56
A new IFRA Standard on the fragrance ingredient, hydroxyisohexyl 3-cyclohexene carboxaldehyde.   
Contact Dermatitis 2010 Apr;62(4):254-255   abstract
_______________________________________________________________

To subscribe to future Digest installments , subscribe here, and we will notify you when the new Digest is published.